INS and type 2 diabetes mellitus: Together, these mechanisms perpetuate systemic IR via a bidirectional loop, where inflammation reduces insulin responsiveness, and this diminished insulin action potentially exacerbates weight gain, amplifying inflammatory cytokine production and driving progressive adiposity, metabolic dysfunction and T2D risk (83, 84).